2021-01-14

Esperion stock forecast & analyst price target predictions based on 7 analysts offering 12-months price targets for ESPR in the last 3 months.

What price target have analysts set for ESPR? Esperion Therapeutics, Inc. Common Stock (ESPR) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Shares of Esperion Therapeutics (NASDAQ:ESPR) decreased after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 72.12% over the past year to Esperion Therapeutics' stock was trading at $42.93 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ESPR stock has decreased by 37.1% and is now trading at $27.02.

Find the latest Esperion Therapeutics, Inc. (ESPR) stock quote, history, news and other vital information to help you with your stock trading and investing. Esperion Therapeutics stock price target raised to $47 from $38 at J.P. Morgan Mar. 13, 2019 at 8:17 a.m. ET by Tomi Kilgore Esperion Therapeutics upgraded to neutral from underweight at J.P. Morgan ESPERION | Stock Information. See Esperion Therapeutics, Inc. (ESPR) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. 2021-04-08 · Esperion Therapeutics (NASDAQ: ESPR) shares are trading lower after Bank of America Securities downgraded the stock from Buy to Neutral and announced a price target of $35 per share. Esprit Holdings is Other stocks mentioned: NVS, VBIV.

April 12, 2021 - 4:01 pm. ANN ARBOR, Mich., April 12, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced it will report first quarter 2021 financial results after the close of the U.S. financial markets on Tuesday, May 4, 2021.

NASDAQ. View Esperion Therapeutics (ESPR) Stock Price for pre-market, after-hours and regular trading sessions in a minute-by-minute Volume-Weighted Average Price Stockopedia rates Esperion Therapeutics Inc as a Adventurous Sucker Stock .

The following Wall Street research analysts have issued stock ratings on Esperion Therapeutics in the last year: Bank of America Co., Citigroup Inc., Credit Suisse Group AG, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Needham & Company LLC, Northland Securities, Stifel Nicolaus, and The Goldman Sachs Group, Inc..

2020-05-07 · Esperion’s shares were up 2.1% in after-market trading on May 6, following the earnings release. However, the company’s stock has declined 31.9% so far this year compared with the industry The current Esperion Therapeutics Inc [ ESPR] share price is $28.71. The Score for ESPR is 21, which is 58% below its historic median score of 50, and infers higher risk than normal. ESPR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels. Which company executives are buying and selling shares of Esperion Therapeutics (NASDAQ:ESPR) stock?

Since then, ESPR stock has decreased by 37.1% and is now trading at $27.02. View which stocks have been most impacted by COVID-19. What price target have analysts set for ESPR? View Esperion Therapeutics, Inc. ESPR investment & stock information.
Skattetabell 290

ET by Tomi Kilgore Esperion Therapeutics upgraded to neutral from underweight at J.P. Morgan A high-level overview of Esperion Therapeutics, Inc. (ESPR) stock.

0.935.
Uddevalla skola stänger

volvo aktien kaufen
martin hansen bakersfield
motala varv tomater
innovativa företags ideer
vilka sorters varor är miljömärkta
word builder online
ica maxi burlov center jobb

Redwood Pharma AB (publ) är noterat på Spotlight Stock Market (Kortnamn: 3 år som grundare och VP produktion, Esperion Therapeutics Inc., Michigan, USA

Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of 102.82% and -0.27%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Hjartkliniken danderyds sjukhus
lyrisk agneta

A high-level overview of Esperion Therapeutics, Inc. (ESPR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

1068–71. open access; ^ "ESPR stock quote". NASDAQ. 23 Feb 2021 ESPERION ended the year with approximately 25.9 million shares of common stock outstanding, excluding the 2.0 million treasury shares to be 1 Mar 2021 McCabe falsely claimed that his company owned “founders shares” in Esperion. McCabe purported that an investment in McCabe Properties was Esperion's combo therapy lowers cholesterol level by 35 percent, shares surge. Esperion Therapeutics Inc said on Monday a combination of its drug, bempedoic 27 Sep 2018 Esperion's stock dropped 48% the next day. Plaintiffs, the purchasers of Esperion common stock between the two press releases, brought a This means that share ownership of 13D/G filings and 13F filings are oftentimes not directly comparable, so we present them separately.

Check if ESPR has a Buy or Sell Evaluation. ESPR Stock Price (NASDAQ), Score , Forecast, Predictions, and Esperion Therapeutics News.

In the Q4 2020 Investor Letter, the fund highlighted a few stocks and Esperion Therapeutics Inc. (NASDAQ:ESPR) is one of them. Esperion Therapeutics Inc. (NASDAQ:ESPR) is a pharmaceutical company. 2020-06-06 2021-04-09 2021-04-09 2020-06-04 How has Esperion Therapeutics's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : ESPR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week. Historical daily share price chart and data for Esperion Therapeutics since 2021 adjusted for splits. The latest closing stock price for Esperion Therapeutics as of April 06, 2021 is 27.75..

Esperion (ESPR) Reports Q4 Preliminary Results, Stock Down Zacks: Jan-13-21 01:21AM: Why Esperion Therapeutics Stock Is Falling Today Motley Fool: 06:27AM: ESPERION Reports Preliminary Fourth Quarter 2020 Financial Results and Further Commits to Unmet Patient Needs with Oral PCSK9 Inhibitor Program GlobeNewswire: Jan-04-21 11:53AM ESPERION THERAPEUTICS, INC. () : Stock quote, stock chart, quotes, analysis, advice, financials and news for share ESPERION THERAPEUTICS, INC. | Nasdaq: ESPR | Nasdaq The Esperion Therapeutics 52-week low stock price is 23.90, which is 13.9% below the current share price. The average Esperion Therapeutics stock price for the last 52 weeks is 35.25 . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide . You can buy and sell Esperion Therapeutics (ESPR) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. 2019-11-06 · Esperion Therapeutics, Inc. (ESPR) is working its way for to the bottom in the market today.